Top

Published in:

01-12-2017 | Erratum

Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status

Authors: Rachel L. Delfanti, David E. Piccioni, Jason Handwerker, Naeim Bahrami, AnithaPriya Krishnan, Roshan Karunamuni, Jona A. Hattangadi-Gluth, Tyler M. Seibert, Ashwin Srikant, Karra A. Jones, Vivian S. Snyder, Anders M. Dale, Nathan S. White, Carrie R. McDonald, Nikdokht Farid

Published in: Journal of Neuro-Oncology | Issue 3/2017

Excerpt

In the initial online publication, the values in the last two rows in Table 1 were in the wrong rows. The original article has been corrected. …

Title: Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status
Authors: Rachel L. Delfanti
David E. Piccioni
Jason Handwerker
Naeim Bahrami
AnithaPriya Krishnan
Roshan Karunamuni
Jona A. Hattangadi-Gluth
Tyler M. Seibert
Ashwin Srikant
Karra A. Jones
Vivian S. Snyder
Anders M. Dale
Nathan S. White
Carrie R. McDonald
Nikdokht Farid
Publication date: 01-12-2017
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2017
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-017-2620-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2017

Current trends in mouse models of glioblastoma

Estimating progression-free survival in patients with glioblastoma using routinely collected data

Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry

Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas

Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma

Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status